Breaking
RAPS Euro Convergence 2026: Regulatory News - Day 1 RoundupHeart Failure 2026: Vutrisiran Data & European Pharma NewsMifepristone Access Continues Under Supreme Court Hold as Planned Parenthood Responds to 5th Circuit Ruling
🌏 NMPA

Neonatal Care

Page 1 • 1 item

Global neonatal care market intelligence for pharma BD, investors & analysts. Stay ahead on drug development, regulatory shifts & therapeutic innovation.

Prolacta's Human Milk-Based Fortifiers Receive World's First Prescription Drug Status in Japan Following JASMINE Trial Success
NewsNeonatal Care/Medical NutritionMay 1, 2026

Prolacta's Human Milk-Based Fortifiers Receive World's First Prescription Drug Status in Japan Following JASMINE Trial Success

Prolacta achieves global regulatory milestone as Japan grants prescription drug status to human milk-based fortifiers for premature infants based on JASMINE trial data.

Dr. Priya Sharma